The effect of aging on skeletal muscle regeneration by Reinking, Ben E.
University of Northern Iowa
UNI ScholarWorks
Presidential Scholars Theses (1990 – 2006) University Honors Program
1996
The effect of aging on skeletal muscle regeneration
Ben E. Reinking
University of Northern Iowa
Follow this and additional works at: http://scholarworks.uni.edu/pst
Part of the Physiology Commons
Let us know how access to this document benefits you
This Open Access Presidential Scholars Thesis is brought to you for free and open access by the University Honors Program at UNI ScholarWorks. It
has been accepted for inclusion in Presidential Scholars Theses (1990 – 2006) by an authorized administrator of UNI ScholarWorks. For more
information, please contact scholarworks@uni.edu.
Recommended Citation
Reinking, Ben E., "The effect of aging on skeletal muscle regeneration" (1996). Presidential Scholars Theses (1990 – 2006). 10.
http://scholarworks.uni.edu/pst/10
The Effect of Aging on Skeletal Muscle Regeneration 
Ben E. Reinking, University of Northern Iowa, 1996 
Faculty Advisor: Carl Thurman, Ph. D. 
Sponsored By: Frank W. Booth, Ph. D., Integrative Biology, UTH 
Supported By: National Institute of Health AR41995 
Signed ;
Carl Thurman, Ph. D. 
5-3-96 
Abstract: 
Muscle atrophy and decreased strength are an accepted part of 
ag1ng. While physical inactivity may account for some of these 
losses, physically active individuals still exper1ence age related 
reduction in muscle mass and strength. The purpose of this study 
is to examine the effects that aging has on skeletal muscle 
regeneration. It is hypothesized that the recovery of muscle mass 
and force following muscular injury will decrease with age. The 
anesthetic bupivacaine, a potent myotoxic agent, was injected 
into the left tibial is anterior (TA) of young, adult, and 
senescent rats (3, 18, 31 months). The right leg served as an 
internal control. Following a 2, 3, or 4 week recovery period, 
the mass and isometric force of each TA were measured. In the 
young animals, the mass of the bupivacaine injected leg was 60% of 
the control value at two weeks post injection. By three weeks, 
the mass was fully recovered. In the middle age and senescent 
animals, mass of the injected TA was approximately 50% of the 
control at two weeks and remained at 50% of control following 3 
and 4 weeks recovery. Muscle force measurements demonstrated 
parallel trends. These results indicate that skeletal muscle 
regeneration is impaired in middle age and senescent rats. 
Recently, a family of four genes was identified that causes 
the express1on of skeletal muscle specific proteins when activated 
1n precursor cells. One member of this family is myogen1n. It 1s 
known that myogenin is expressed only during skeletal muscle 
regeneration, making it an excellent marker for this process. 
Myogenin mRNA levels were measured in the control and experimental 
TA muscles of the young , middle age, and senescent animals used 
in this experiment. All three age groups have elevated levels of 
myogen1n mRNA in the bupivacaine-injected TA when compared to the 
control. In addition, the 31 month animals have significantly 
higher levels of myogenin mRNA in their control legs at all time 
periods than those found in the other age groups . It is known 
that the expression of myogenin is down-regulated by electrical 
activity. The high levels found in the control leg indicate 
reinnervation problems during regeneration in the old animals . 
Introduction: 
Webster's Compact Dictionary defines disease as, "a 
condition of the body that impairs its normal functioning . " 
Skeletal muscle atrophy is prevalent among the elderly and is a 
leading cause of impaired mobility in the aging members of our 
population. (Fitarrone et al., 1994). Such a loss of mobility 
leads to dependence and greatly decreases the quality of life in 
the later years. In addition, it was estimated that$ 10 billion 
are spent yearly to treat fall related fractures in the elderly 
that occur as a direct result of insufficient muscle strength and 
endurance (Tinetti et al., 1994). While these decreases 1n 
muscular strength and mobility are often attributed to a sedentary 
lifestyle, trained athletes who show higher strength and power 
than normal individuals, still experience similar declines in 
structural and functional properties throughout their lifetime 
(Brooks and Faulkner, 1994). Despite the obvious impairment of 
normal functions caused by muscle atrophy with aging, the medical 
field has done little to investigate the causes behind this loss. 
Quetelet (1835) originally correlated impaired skeletal 
muscle function with age over 150 years ago. Since that time, a 
significant amount of information has been gathered on the 
subject. Today it 1s known that human skeletal muscle begins to 
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atrophy at 25 years of age in men. Muscle mass decreases 10% over 
the next 25 years without a corresponding loss in strength (Lexall 
et. al. 1986). After the age of 50, however, there is a 30% loss 
of muscle mass by the age of 80. Closely associated with this is 
a 22% loss of muscle strength that occurs between the ages of 45-
50 and 60-65 years of age ( Larrson et al . , 1978). Similar losses 
of mass and strength occur a few years later in women. While 
other possibilities have been proposed, an increased 
susceptibility to injury coupled with a decreased ability to 
recover from injury may be a major cause of muscle atrophy and 
weakness seen in old animals and the elderly . 
Skeletal muscle is a dynamic tissue. It 1s constantly 
injured and repaired throughout the course of a normal day due to 
the contractions that allow for movement. Such damage 1s 
generally focal in nature, with 20 - 30% of muscle fibers being 
damaged during eccentric exerc1se. When studying regeneration, it 
is often advantageous to observe wide spread muscular damage. As 
a result, various methods including pinching, freezing, and 
anesthetic injections have been used to induce the degeneration/ 
regeneration process in laboratory animals. The ability of 
skeletal muscle to regenerate following such injury is well 
documented, although the extent and success of regeneration var1es 
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with the extent and cause of injury (Grounds, 1991). 
Following extreme damage, muscles lose their ability to 
contract, but regain some degree of function during regeneration. 
Of particular interest, is the recovery of contractile properties 
following a localized injection of the anesthetic bupivacaine. 
Following grafting, pinching, or freezing, contractile properties 
are only partially restored (Carlson et al., 1983). After a 
bupivacaine injection, however, muscle mass and contractile 
properties are completely restored within 3-4 weeks 
(Rosenblatt, 1992). Only 15 minutes after the injection of 
bupivacaine, the sarcolemma is disrupted, the sarcoplasmic 
reticulum dilates, myofibrils hypercontract, and the myonuclei are 
disrupted (Bradley, 1979). Over the next 12 hours, the myofibrils 
rupture, and the sarcolemma dissolves resulting in cytoplasm 
fragmentation (Hall-Craggs 1974). Macrophages begin to engulf 
necrotic fibers at 12 hours post injury and infiltrate the tissue 
by 24 hours (Nonaka et. al . , 1983). Myoblasts are observed after 
the first day and fuse to form mature myotubes within 4 weeks 
(Rosenblatt, 1992). 
The fast action and complete recovery are due to the 
selective action of the drug on myofibrils and lack of damage to 
the muscle's satellite cell population (Hall-Craggs, 1980b), basal 
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lamina (Hall-Craggs, 1980a), vascular supply (Grim et al., 1983) 
and intramuscular nerves (Tomasi Ferre et al., 1989). The other 
methods selectively damage one or more of these 3 elements, 
greatly limiting regenerative possibilities. Thus, bupivacaine 
provides an excellent opportunity for studying skeletal muscle 
regeneration in an ideal environment. 
The regenerative process involves revascularization, invasion 
of phagocytic cells, removal of damaged tissue, proliferation and 
fusion of precursor cells, and reinnervation (Grounds, 1991). 
Each of these steps 1s necessary. Without their ordered 
occurrence regeneration is not successfully completed. The 
following is a brief discussion of the events that occur during 
regeneration. 
Revascularization 1s extremely important to the regeneration 
of skeletal muscle. Upon removal of the vascular supply, the 
majority of the myotubes, except for a few at the periphery, 
degenerate. The peripheral fibers are kept alive by the diffusion 
of nutrients and gases from vessels in neighboring tissues 
(Carlson, 1981). In general, regeneration trails behind 
revascularization because blood supplies the oxygen and nutrients 
necessary for new tissue formation. The mechanisms behind 
revascularization are poorly understood. It is known that the new 
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vascular tissue comes from small neighboring vessels rather than a 
major vessel. This indicates that angiogenic factors released 
from the area of injury may cause local blood vessels to branch 
towards the damaged tissue. Such factors have yet to be 
identified. 
Slightly before revascularization, a few macrophages enter 
the damaged tissue and begin removing debris (Hansen-Smith et al., 
1979 and Roberts et al., 1990). Shortly following 
revascularization, a wave of leukocytes enters the tissue and 
phagocytizes the debris. This process is important because 
regeneration is inhibited by persisting necrotic tissue. Removal 
of dead tissue creates room for new myotubes to form. 
The normal growth and repair of muscle fibers is carried out 
by satellite cells. These are undifferentiated muscle precursor 
cells located between the sarcolenma and basal lamina of a muscle 
fiber. They cause normal growth and repair by either fusing with 
existing fibers (hypertrophy) or forming new myotubes 
(hyperplasia) (Schultz, 1990). In addition, satellite cell 
proliferation is responsible for the addition of new myonuclei 1n 
regenerating muscles (Snow, 1977). Satellite cells are normally 
quiescent and are activated following injury. The factors that 
directly or indirectly control their proliferation and fusion are 
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unknown due to the complexity of the situation. It is known, 
however, that a decrease in either satellite cell number or 
activity would decrease regenerative capabilities. 
The establishment of a functional neuromuscular synapse 1s 
critical for the maturation of regenerating muscle fibers. 
Without neural activity, the regenerating tissue dies. Motor 
axons generally make contact with regenerating tissue in the same 
area as the original endplate. Although neighboring axons can 
sprout and innervate the regenerating tissue, the same axon that 
innervated the fibers before injury generally innervates the 
regenerated fibers (Fowler, 1994). It is also known that nerve 
growth factor (NGF) acts as a chemotactic agent and is responsible 
for the sprouting of axons. 
An extremely important step during regeneration is 
myogenes1s. Myogenesis is characterized by the proliferation and 
fusion of satellite cells. Under normal conditions, satellite 
cells are inactive. Following injury, however, they are 
activated. Such activation occurs via a recently identified 
family of genes. This family consists of myogenin (Edmonson and 
Olson, 1989), Myo 01 (Davis et al., 1987), myf 5 (Braun et al., 
1989), and herculin/MRF 4 (Miner and Wold, 1990). All four genes 
have homologous sequences, including an area which codes for a 
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ser1es of basic am1no acids that is responsible for the DNA 
binding ability of the proteins (Davis et al., 1990). Their 
express1on ultimately leads to the expression of muscle specific 
proteins. Recent studies report that predominantly quiescent 
satellite cells do not express any members of the myogenic family 
(Grounds et al., 1992 and Fuchtbauer & Westphal, 1992). In 
addition, Grounds (1991) reported that the expression of myo 01 
and myogenin was apparent six hours following crush injury to 
skeletal muscle. Thus, myogenin is only expressed in regenerating 
skeletal muscle, making it an excellent marker for this process. 
In light of this information, the purpose of this study is to 
examine the effects of aging on skeletal muscle regeneration . More 
specifically, the temporal relationship of muscle regeneration, 
recovery of muscle force, and myogenin mRNA expression in young, 
adult, and aged rat skeletal muscle are investigated. The 
following hypotheses are tested: 
1) Recovery of muscle mass and force generating capacity following 
injury occurs later with age. 
2) The expression of myogenin mRNA will differ 1n the regenerating 
muscle of young, adult, and aged rats. 
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Results of this experiment indicate that skeletal muscle 
regeneration is impaired with age, pointing to it as a probable 
cause of age-related atrophy. 
Methods: 
Animals: The rats used in this experiment were male Brown Norway-
Fischer 344 cross. Fifteen 3 month, 18 month, and 33 month rats 
were purchased from the NIH Aging program in Indianapolis. Upon 
arrival they were placed in temperature (21°C) and light C 12:12 
hr . light/dark) controlled quarters in the University of Texas-
Houston Medical Center animal care facility. The rats were housed 
two per cage and isolated from other animals. All food and water 
was sterilized by autoclave. Protocols were approved by the 
Institutional Animal Welfare Committee. 
Bupivacaine Injection: The animals were anesthetized with an 
intramuscular injection (0.84 ml/kg) of ketamine(54 mg/ml), 
xylazine (2.2 mg/ml), and acepromazine (3.5 mg/ml). An incision 
was made over the distal third of the left tibial is anterior (TA). 
A 25 gauge 5/8" needle (0.5x16 mm) needle was inserted along the 
longitudinal axis of the muscle. While the needle was slowly 
withdrawn, 0.5 ml of 0.75% bupivacaine was injected into the 
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muscle. A similar injection was administered at a 15° angle, 3 nm 
away from the original injection. The right leg was undisturbed 
and served as an internal control. Once the animals recovered, 
they were returned to their cages. 
Force Measurements: Following two, three, or four weeks recovery 
the rats were anestithized with an intramuscular injection of the 
ketamine cocktail described earlier. An incision was made through 
the quadriceps femoris, exposing the deep peroneal nerve. Two 
electrodes were sutured to the nerve. The nerve was severed to 
prevent stimulation of the lower limb via the central nervous 
system. The rats were placed in a heated box. Anesthetic causes 
body temperature to drop. Any significant change in body 
temperature would have affected force measurements. A stimulator 
was wired to the electrodes. The tendon of the TA was attached to 
a force transducer. Computer programs were used to determine 
optimal muscle length and current for force measurement. Force 
measurements were taken at 50, 75, 100, 150, 200, 250, and 300 HZ. 
Average force was calculated for each leg using the frequency that 
caused tetany. 
Muscle Sampling: Inmediately following force measurements the 
rats were anestithized and the TA was removed from each limb. They 
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were frozen with liquid nitrogen-cooled Wollenberger tongs. 
Muscle samples were frozen at -80°( until further analysis. Rats 
were sacrificed by cervical dislocation while under anesthesia. 
Total RNA Isolation and Quantification: Tibial is anterior 
muscles were individually powdered under liquid nitrogen using a 
mortar and pestle. Total RNA was extracted from 150-300 mg 
samples of each muscle using the guanidine thiocyanate method of 
Chomczynski and Sacchi (1987) with Trisolve (Biotecx 
Laboratories). The RNA was dissolved in diethylpyrocarbonate 
treated water and quantified spectrophotometrically at 260 nm. 
RNA integrity was confirmed by examining an ethidiumbromide 
stained gel of 18S and 28S rRNA prior to its use in Northern 
Blots. 
Myogenin mRNA determination: Northern blot analysis was 
used to assess the concentration of myogenin in all muscles. 
Separate 15 ug samples of RNA were loaded onto 1% agarose / 6.7% 
formaldehyde gels and electrophoresed at 5 V/cm for 2.5 hours. 
The RNA was transferred to nylon membranes via capillary action 
and ultraviolet cross-linked to the membrane (Carson et.al.,1995). 
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Full length cDNA for rat myogenin provided by Dr. Victor K. 
Lin was subcloned into the plasmid vector pBluescript (Wright et 
al., 1989). A cDNA insert was cut from the plasmid (EcoRI) and 
random primed. The RNA containing membrane was prehybridized 
with 12 ml of hybridization buffer (Quick Hyb, Stratagene) for 30 
minutes at 68°C. An aliquot of random primed myogenin cONA probe 
was mixed with the hybrization buffer and incubated for 2 hours at 
68°C. The membrane was then washed twice in Zx sodium chloride -
sodium citrate (SSC) - 0.1% sodium dodecylsulfate (SOS) for 15 
minutes at 20°c. It was washed again with 0.1 SSC - 0.1 SOS for 
30 minutes at ss0 c. The membrane was autoradigraphed (-80°C, 30 
min.) and the band corresponding to myogenin mRNA was quantified 
by densitrometric scanning (Bioimage) and normalized to ethidium 
bromide stained 28s rRNA. 
Statistical Analysis: All statistical analysis was done us1ng a 
standard statistical package on a Macintosh computer. The 
software used was Gopher. 
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Results: 
Muscle Mass and Force: The mass of the individual control and 
bupivacaine injected TA muscles are compared for each age group 
(Fig. 1). At two weeks post-injection, the mass of the injected 
TA (3 mo. rats) was 77 % of control values. At three weeks it was 
105% of the control value. It remained at this level at four 
weeks post-injection. In the 18 month animals, injected muscle 
mass was 53%, 64%, and 64% of control values following 2,3, and 4 
weeks recovery respectfully. The results from the 31 month 
animals parallel those from the 18 month animals. Experimental 
muscle mass for the 31 month animals was 60%, 63%, and 67% of the 
control values at 2, 3, and 4 weeks following the bupivacaine 
injection. 
Results of the force measurements (Fig. 2) are similar to 
those for muscle mass. In the 3 month animals, the force produced 
by the bupivacaine injected leg was 58% of the control at 2 weeks, 
95 % of the control at 3 weeks, and 105% of the control at four 
weeks post-injection. Force measurements for the adult animals 
were 34% of the control at 2 weeks, 30% of control at 3 weeks, and 
46% of control at 4 weeks post injection. In the aged animals, 
the force produced by the bupivacaine injected TA was 37% of the 
control muscle. This did not 1ncrease significantly at 3 or 4 
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weeks. 
Statistical analysis of this data by the Student - Newman -
Keuls test and the Turkey - Kramer test indicated significant 
differences between young and adult animals and young and old 
animals for both muscle mass and force. The difference between 
the adult and old animals, however, was not significant. In 
addition, a strong correlation existed between the recovery of 
muscle mass and force production. 
Myogenin mRNA: The presence of myogenin is a powerful indicator of 
muscle damage. In all three age groups and at all three time 
periods, myogenin mRNA express1on in the bupivacaine injected legs 
was greater than 100 % of control values (Fig. 3). Myogenin mRNA 
decreased slightly between 14, 21, and 28 days 1n the young rats. 
It remained elevated at all three time periods 1n the adult rats. 
It increased significantly from 14 -28 days in the old rats. In 
addition, the control leg of the old rats had significantly higher 
myogenin mRNA levels at all three time periods than the control 
legs of the young or adult rats (Fig.4). 
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Discussion: 
This experiment supports the general proposal that skeletal 
muscle regeneration is inhibited with age. The hypothesis that 
the recovery of muscle mass and force generating capacity 
following injury occurs later with age is supported by the present 
set of experiments. As seen in figures 1 and Z, the young rats 
recover from injury significantly sooner than the adult and old 
rats. The lack of a significant difference between the adult and 
old rats, however, is surprising. A qualitative experiment done 
by Menachem Sadeh (1988) found that both degeneration and 
regeneration were most active in young animals, decrease slightly 
in middle age, and are markedly impaired in senescence. Similar 
results are expected here, but are not observed. One explanation 
for this observation could be the age of the adult rats. In most 
cases, an adult rat is considered to to be 9-12 months of age. 
However, due to the long life span of the Brown Norway-Fischer 344 
cross, 18 months 1s considered middle age. Although this breed of 
rat has a longer life span than others, it is possible that the 
aging process begins at the same time. If this is the case, then 
an 18 month rat is considered old and regeneration is already 
inhibited. 
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The results of the myogen1n mRNA analysis are very 
interesting. The mRNA levels in the control leg are slightly 
higher than normal. This is because experimental legs were 
useless due to the bupivacaine injection, caus1ng the control legs 
to relied upon more heavily than normal. This extra use caused 
slight damaged to fibers, resulting in satellite cell activation. 
As expected, myogenin mRNA levels in the experimental legs are 
significantly higher than in the control legs for all age groups 
and at each time period. This indicates a higher than normal 
degree of satellite cell activation, which directly correlates to 
increased regeneration. 
Myogenin mRNA levels 1n both the control and bupivacaine 
legs of the old animals are significantly higher than those found 
in the young or adult animals. It is known that myogenin is down 
regulated by electrical activity ( Eftimie et. al. 1991). High 
levels indicate a lack of electrical activity. This could be due 
to poor reinnervation of newly formed myotubes 1n the old rats. 
Without proper innervation, muscle fibers die and the regenerative 
capacity of old rats is decreased. A loss of alpha motor neurons 
and motor units has been well documented (Ansved and Larson, 
1990). The exact cause of this loss, however, is unknown. 
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This result indicates that it is not the regenerative 
capacity of muscle cells, but changes in the environment which 
inhibits regeneration with age. This result is supported by a 
prev1ous study which found that old animals show a decreased 
regenerative capacity following free whole muscle transplantation 
(Foster, 1980). Under these circumstances, the whole muscle 
degenerates as a result of the ischemic injury. It was found that 
muscles from young or old rats transplanted into young animals 
regenerated equally well, but muscles from young or old rats 
transplanted into old rats regenerated equally poorly (Carlson and 
Faulkner, 1989). It is not the regenerative capacity of the cell, 
but the environment in which the regeneration occurs that impairs 
this process in aging animals . 
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Figure 1 . Relative percent changes in the mass of bupivacaine-
injected TA's of young (3 months), middle age (18 months), and old 
rats (31 months) compared to the contralateral control at 2, 3, 
and 4 weeks after the injection . 
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Figure 2. Relative percent changes in force production by the 
bupivacaine-injected TA compared to the contralateral control 2, 
3, and 4 weeks after injection in young (3 months), middle age (18 
months), and old (31 months) rats . Plotted values are means + 
SE. 
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Figure 3. Relative percent changes in myogen1n mRNA content in 
the bupivacaine-injected TA compared to the contralateral control 
2, 3, and 4 weeks after injection in young C 3 months), middle age 
(18 months), and old (31 months) rats. 
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Figure 4. Myogenin mRNA levels in the control and bupivacaine 
injected legs of young (3 months), middle age (18 months), and old 
(31 months) rats 2, 3, and 4 weeks post-injection. 
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